I’m Covering the Practice of a "Dr. Feel Good"

Note: This article is for informational purposes only and reflects current U.S. clinical and regulatory guidance. It is not a substitute for individualized medical care, legal advice, or professional judgment.

Walking into another clinician’s practice is a little like house-sitting for someone who swore, “Everything is under control,” right before disappearing into the night. Sometimes it really is fine. The plants are watered. The chart notes are tidy. The refill requests are civilized. And sometimes you open the door and find a waiting room full of anxious patients, a medication list that reads like a controlled-substance bingo card, and a sinking realization that you have inherited not just a practice, but a problem.

That is the world behind the nickname “Dr. Feel Good.” In medical slang, it usually refers to a clinician who becomes known for handing out medications that make patients feel better fast, especially controlled substances, without enough diagnostic rigor, monitoring, caution, or long-term planning. The phrase may sound like a bad lounge act from 1978, but the consequences are not retro-charming. They are serious.

When a covering physician steps into that kind of practice, the challenge is not simply saying “no” to risky prescriptions. The real challenge is far more complicated: protecting patients, avoiding abrupt harm, rebuilding trust, correcting unsafe habits, documenting clearly, and doing all of that while people in distress are staring at you as if you personally invented disappointment.

What Makes a “Dr. Feel Good” Practice So Hard to Cover?

The difficulty usually begins with one dangerous illusion: a long-standing prescription can look like proof that a treatment is appropriate. It is not. A medication may be old, familiar, and fiercely defended by the patient, yet still be unsafe, poorly indicated, badly monitored, or part of a combination that raises the risk of overdose, misuse, cognitive impairment, falls, emergency visits, or escalating dependence.

Still, the opposite mistake is just as harmful. The covering clinician cannot march in like a sheriff in a medical western and shut everything down by lunch. Patients may be physically dependent on one or more medications. Some may have legitimate diagnoses of chronic pain, panic disorder, insomnia, or ADHD. Some may have been poorly managed. Some may have been overmedicated. Some may have both real symptoms and a substance use disorder. Real life, annoyingly, refuses to sort itself into neat little bins.

That is why this situation is so stressful. A “Dr. Feel Good” practice tends to create three layers of instability at once:

• Clinical instability, because medication regimens may be risky, redundant, or poorly justified.
• Relational instability, because patients often arrive expecting continuation, not re-evaluation.
• Operational instability, because the covering clinician must review records, field refill requests, handle staff anxiety, and manage a panel shaped by someone else’s prescribing habits.

In other words, you are not just inheriting a prescription pad legacy. You are inheriting its ecosystem.

The Classic Trouble Trio: Opioids, Benzodiazepines, and Stimulants

If there is a signature pattern in a “Dr. Feel Good” panel, it is often some variation of the controlled-substance trifecta: an opioid for pain, a benzodiazepine for anxiety or sleep, and a stimulant for attention or energy. Each medication class can be appropriate in the right patient and under careful supervision. The problem is not that these drugs exist. The problem is careless prescribing, lazy follow-up, weak monitoring, and combinations that multiply risk faster than anyone in the room wants to admit.

Opioids

Opioids may have a role in select situations, but they are not magic and they are certainly not vitamins with brand names. Over time, they can bring tolerance, physical dependence, constipation, sedation, cognitive dulling, and overdose risk. For chronic pain, the long-term benefit is often less impressive than patients and prescribers hope. The modern view is not “opioids are evil,” but rather “opioids require real stewardship.” That means the right indication, the lowest effective dose when appropriate, regular reassessment, and a serious conversation about risks, function, and alternatives.

Benzodiazepines

Benzodiazepines can calm panic, reduce acute anxiety, and help in carefully selected cases. They can also impair memory, increase sedation, create physical dependence, and make withdrawal miserable when stopped too quickly. When layered on top of opioids, the danger rises because both can suppress breathing and cloud thinking. That combination is one of the biggest red flags in any inherited practice, especially when there is little documentation explaining why the patient remains on both drugs long-term.

Stimulants

Prescription stimulants have an important place in the treatment of ADHD and certain other conditions. But in a loose, poorly monitored practice, they can drift from therapeutic use into lifestyle enhancement, diversion, misuse, refill drama, or “I only lost them because my cousin’s ferret knocked over my backpack” territory. A covering clinician must distinguish appropriate treatment from pressure, performance culture, and casual sharing, because stimulants are controlled substances for a reason.

The Biggest Mistake: Confusing Compassion With Automatic Refills

A permissive prescriber often wins loyalty because medications can provide immediate relief, and immediate relief is persuasive. It feels kind. It feels responsive. It feels like the doctor is listening. But good medicine is not measured by how quickly a refill is sent. It is measured by whether the treatment is justified, safe, monitored, and aligned with the patient’s actual diagnosis and long-term welfare.

This is where covering clinicians get trapped. If they continue everything exactly as before, they may reinforce a dangerous system. If they stop everything abruptly, they may trigger withdrawal, panic, rage, illicit drug seeking, or a complete collapse of the therapeutic relationship. The answer is not blind continuation or theatrical crackdowns. The answer is structured, patient-centered reset.

That reset starts with a simple principle: patients should never be abandoned, even when a prescribing plan needs to change. That principle matters morally, clinically, and legally. It also matters practically, because an abandoned patient does not become safer. They become desperate.

How a Covering Clinician Can Clean Up the Mess Without Making a Bigger One

1. Review the chart like it owes you money

The inherited medication list is only the headline. The story is in the chart. Why was each controlled substance started? What diagnosis supports it? What noncontrolled alternatives were tried? What happened at follow-up visits? Are there signed treatment agreements, urine drug screens, PDMP checks, specialist consultations, behavioral therapies, or documented functional goals? If the answer is mostly crickets, the covering clinician has learned something important.

2. Reassess the patient, not just the prescription

People are not refill machines with shoes. A real reassessment means asking what symptoms remain, how the medication helps, what side effects exist, whether function has improved, whether there have been early refill requests, whether multiple prescribers are involved, whether alcohol or other sedating drugs are in the mix, and whether the patient shows signs of misuse, diversion, or substance use disorder. This is not punishment. It is medicine.

3. Use monitoring tools without turning into a robot

Checking the prescription drug monitoring program, reviewing refill patterns, considering toxicology testing when appropriate, and documenting clear reasoning are now part of responsible controlled-substance care. These steps are not accusations. They are guardrails. Inherited panels often feel insulted when monitoring suddenly appears, but the clinician’s job is not to be mistaken for a vending machine with a stethoscope.

4. Avoid abrupt discontinuation whenever possible

This is crucial. Even when a regimen is plainly problematic, sudden stoppage can be dangerous. A patient may be physically dependent, especially on opioids or benzodiazepines. Safe care often means stabilizing first, then creating a gradual plan: a slower taper, closer follow-up, a narrowed regimen, a shift to safer alternatives, referral for specialty care, or evaluation for substance use treatment. Good medicine can be firm without being reckless.

5. Explain the “why” in plain English

Nothing inflames a visit faster than vague moralizing. Patients deserve clarity. A useful script sounds something like this: “I am not saying your symptoms are fake. I am saying this combination carries risks that concern me, and I want to work with you on a safer plan.” That is a very different message from, “Your last doctor was wrong and today the fun police arrived.” One opens a conversation. The other opens a war.

6. Offer an alternative plan, not just a refusal

Patients often hear “no” as abandonment unless it is followed by “here is what we can do instead.” That might include nonopioid pain strategies, physical therapy, behavioral treatment for anxiety or insomnia, formal ADHD reassessment, naloxone education when overdose risk is present, specialist referral, closer visit intervals, and clear medication boundaries. A safer plan needs structure, not just noble intentions.

Why Patients Stay in These Practices

It is easy to caricature patients in a “Dr. Feel Good” practice. It is also lazy. Many are not scheming villains with sunglasses and suspiciously dramatic refill stories. Many are frightened, dependent, underdiagnosed, overprescribed, undertreated in other ways, or genuinely convinced that the medications are the only reason they can work, sleep, drive, parent, or keep panic at bay. Some have learned to fear any change because they have never been offered a thoughtful one.

That is why stigma makes these situations worse. The covering clinician has to hold two truths at once: some patients are receiving unsafe care, and those same patients still deserve dignity. The goal is not to humiliate them out of a bad regimen. The goal is to move them toward safer care without pretending the risks are imaginary.

The Legal and Ethical Shadow Behind the Exam Room

Controlled-substance prescribing does not happen in a legal vacuum. There are federal rules, state rules, monitoring systems, documentation expectations, and, in some states, doctor-shopping laws aimed at patients who obtain controlled substances through concealment or deception. On top of that, clinicians and pharmacists carry responsibilities to ensure prescriptions serve a legitimate medical purpose. So when a covering physician pauses, questions a regimen, or requests verification, that is not necessarily distrust. It may be responsible practice under a real legal framework.

But law is not the whole story. Ethics matter just as much. A clinician should not prescribe unsafely just because “the last doctor always did.” Nor should a clinician dump a patient because the panel is messy. The ethical sweet spot is uncomfortable, labor-intensive, and unglamorous: careful review, honest communication, gradual change, and continued care.

What Good Care Looks Like After the Reset

A practice recovering from a “Dr. Feel Good” era often needs a cultural reset, not just a medication reset. Staff need scripts for refill requests. Policies need consistency. Visit intervals may need tightening. Documentation must improve. Patients need to hear the same message from the whole team. The clinician needs enough backbone to say no, and enough humanity to explain it well.

Over time, something important happens. The clinic becomes less chaotic. Fewer “emergency” refill crises appear on Friday afternoons with the dramatic timing of a soap opera. Patients who truly want treatment begin to adjust to a more stable structure. A smaller subset may leave, especially if what they wanted was not care but supply. That is not failure. That is the sorting function of good boundaries.

The deeper lesson is this: the opposite of a “Dr. Feel Good” is not a cold doctor. It is a careful one. A clinician can be warm, validating, funny, and fully human while still refusing to continue a harmful regimen. In fact, that is what good medicine often looks like under pressure.

Conclusion

Covering the practice of a “Dr. Feel Good” is one of those assignments that can age a physician three years in one week. It demands clinical judgment, emotional steadiness, legal awareness, and the ability to communicate like a grown-up in a room where everyone else is tempted to panic. But it also exposes an important truth about modern medicine: kindness is not the same thing as permissiveness, and boundaries are not the same thing as cruelty.

The best covering clinician does not rubber-stamp a risky legacy, and does not torch it overnight either. Instead, they do the harder thing. They slow down. They verify. They explain. They monitor. They taper thoughtfully when needed. They offer alternatives. They refuse to abandon patients. And in a health care system that often rewards speed over wisdom, that kind of practice may be the least flashy thing in the world. It is also the most responsible.

Extra Experiences From the Covering Doctor’s Chair

What does this situation actually feel like in real life? Picture the first Monday morning after the previous doctor leaves. The front desk is already tense. The medical assistant slips you a stack of refill notes thick enough to qualify as a novella. Three patients are angry before you have logged in, two insist they were “promised” same-day refills, and one says the old doctor never made them come in for anything because “he knew I’m stable.” By 9:30 a.m., the phrase “but this is how it’s always been done” has been said so many times it begins to sound like office wallpaper.

Then you start opening charts. One patient has chronic back pain, panic attacks, insomnia, and a stimulant on top of it all, but almost no recent documentation of function, side effects, or rationale for the combination. Another has been getting early refills every few months with explanations that are individually plausible and collectively suspicious. A third is perfectly polite, clearly suffering, and terrified that any medication change means they will spiral. That is the emotional whiplash of covering a “Dr. Feel Good” practice: some people are manipulative, some are medically complicated, and some are simply scared. You do not get color-coded labels. You get fifteen minutes and a heartbeat.

The hardest moments are often not the dramatic ones. They are the quiet ones. The patient who tears up because no one ever explained why mixing certain medications is dangerous. The patient who admits they do not even know whether the pills still help, but they are afraid to stop because the last attempt was miserable. The spouse who says, in a half-whisper, “I’m glad someone is finally looking at this.” Those are the moments that remind you this is not just a prescribing issue. It is a trust issue, a systems issue, and sometimes a grief issue, because people have built entire routines around medications they barely understand.

There is also a weird professional loneliness in it. You are cleaning up choices you did not make, explaining boundaries you did not create, and absorbing frustration that was really built over years. Nobody throws a parade because you checked the PDMP, documented carefully, declined an unsafe refill, and arranged follow-up. Mostly you just survive the day with your integrity intact and your inbox slightly more haunted than before.

But there is a hopeful side. After a few weeks, the temperature in the practice can change. Staff become more confident because the rules are clearer. Patients begin to realize that the new approach is consistent, not personal. Some even relax once they see that “I need to reassess this” does not automatically mean “I don’t care what happens to you.” That shift matters. It is where good practice begins: not with dramatic speeches, but with steadiness.

And maybe that is the real experience worth remembering. Covering a “Dr. Feel Good” is not about playing hero, detective, or villain. It is about becoming the first calm person in a room that has been organized around short-term relief and long-term confusion. It is about replacing reflex with reasoning. It is about showing patients that safer care can still be compassionate. And yes, it is about discovering that the most powerful word in medicine is not always “yes.” Sometimes it is “let’s slow down and do this right.”